Top of page Skip navigation
  • EARLY BIRD REGISTRATIONS EXTENDED

    Register before 18 August and save

  • RAISE YOUR ORGANISATIONS PROFILE

    Exhibitor packages available - reserve your space today

Confirmed speakers so far include:

  • Dr Peter Atkinson, Associate Director, Head of UK Open Innovation - Neurology Business Group, Eisai
  • Nicola Baker-Munton, Chief Execuitve Officer, Stratagem IPM
  • Laurence Barker, Chief Business Officer, Dementia Discovery Fund, SV Health Investors   
  • Professor Sir John Bell, Regius Professor of Medicine, Oxford University 
  • Dr Veronique Birault, Head, Translational Science, The Francis Crick institute
  • Jeremy Curnock Cook, Chairman, International Bioscience Managers
  • Dr John Davies, Chief Scientific Officer, ARUK Drug Discovery Alliance
  • Professor Paul Davis, Co-Founder and Chief Scientific Officer, Mologic and Honorary/Visiting Professor, Universities of Cardiff, Kent and Warwick
  • Dr Kit Erlebach, Head of R&D Continuous Improvement, FUJIFILM Diosynth Biotechnologies 
  • Dr Simon Ellison, Senior Manager, Advanced Therapies, Fisher BioServices
  • Dr Ed Hodgkin, Partner, Syncona Partners
  • Alice Hu Wagner, Managing Director, Strategy Economics and Business Development, British Business Bank
  • Prof Jim Huntingdon, Professor of Molecular Haemostasis, Cambridge University 
  • Nicole Jadjea, Partner, Field Fisher 
  • Dr Panos Kefalas, Head of Health Economics and Market Access, Cell and Gene Therapy Catapult
  • Sarah Kerruish, Chief Patient Officer, Antidote
  • Susie Middlemiss, Partner, Slaughter and May 
  • Dr Jim Mills, Vice President Technical Operations, Abzena
  • Andy Morris, Patient Advocate 
  • Dr Jennifer O’Farrell, Partner, Boult Wade
  • Dr Angela Osbourne, Managing Director, eXmoor Pharma Concepts
  • Dr Vijay Reddy, Chief Medical Officer, Autolus
  • Dr David Reynolds, Chief Scientific Officer, Alzheimer’s Research UK         
  • Angela Silmon, Chief Executive Officer, NewGene 
  • Michael Tappin QC, 8 New Street Square
  • Professor S.S. Vasan, Senior Business Development Manager, Public Health England and Honorary Visiting Professor, University of York 
  • Dr Penny Ward, Chief Medical Officer, Karus Therapeutics 
  • Dr Will West, Executive Chairman, CellCentric and BIA Board 
  • Professor Mark Wilcox, Consultant Microbiologist & Head of Microbiology, Leeds Teaching Hospitals, Professor of Medical Microbiology, University of Leeds and Lead on Clostridium difficile & Chairman of Rapid Review Panel, Public Health England
  • Doris-Ann Williams MBE, Chief Executive, British in vitro Diagnostics Association
  • Kirsty Wydenbach, Deputy Unit Manager and Senior Medical Assessor Clinical Trials Unit, MHRA
  • Dr Jesus Zurdo, Senior Director Strategic Innovation, Lonza Biologics